PROGNOSTICKÉ FAKTORY A KLONÁLNÍ EVOLUCE U CHRONICKÉ LYMFOCYTÁRNÍ LEUKEMIE DETEKOVANÁ METODAMI FLUORESCENČNÍ IN SITU HYB
![CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase | Leukemia CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0255-1/MediaObjects/41375_2018_255_Fig1_HTML.png)
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase | Leukemia
PROGNOSTICKÉ FAKTORY A KLONÁLNÍ EVOLUCE U CHRONICKÉ LYMFOCYTÁRNÍ LEUKEMIE DETEKOVANÁ METODAMI FLUORESCENČNÍ IN SITU HYB
![miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cells | Cell Death & Differentiation miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cells | Cell Death & Differentiation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41418-019-0430-6/MediaObjects/41418_2019_430_Fig1_HTML.png)
miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cells | Cell Death & Differentiation
![Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia | Scientific Reports Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80613-6/MediaObjects/41598_2020_80613_Fig1_HTML.png)
Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia | Scientific Reports
![Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course | Leukemia Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2402537/MediaObjects/41375_2002_Article_BF2402537_Fig2_HTML.gif)
Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course | Leukemia
![Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics | Nature Communications Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-11582-2/MediaObjects/41467_2019_11582_Fig1_HTML.png)
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics | Nature Communications
![Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course | Leukemia Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2402537/MediaObjects/41375_2002_Article_BF2402537_Fig3_HTML.gif)
Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course | Leukemia
![Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics | Nature Communications Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-11582-2/MediaObjects/41467_2019_11582_Fig3_HTML.png)
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics | Nature Communications
![CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase | Leukemia CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0255-1/MediaObjects/41375_2018_255_Fig2_HTML.png)